Man Group’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Man Group’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-30,897	Closed	-$3.66M	–	2196
2021 Q1	$3.66M	Buy	+30,897	New	+$3.65M	0.02%	843
2020 Q3	–	Sell	-21,912	Closed	-$2.24M	–	1946
2020 Q2	$2.24M	Buy	21,912 +7,678	+54%	+$822K	0.01%	1020
2020 Q1	$1.54M	Sell	14,234 -141,327	-91%	-$16.2M	0.01%	986
2019 Q4	$18.1M	Buy	155,561 +90,469	+139%	+$10.5M	0.06%	395
2019 Q3	$7.45M	Buy	+65,092	New	+$6.47M	0.03%	692
2019 Q1	–	Sell	-60,540	Closed	-$4.59M	–	2173
2018 Q4	$4.59M	Buy	60,540 +6,420	+12%	+$472K	0.02%	813
2018 Q3	$4.33M	Sell	54,120 -25,917	-32%	-$2.41M	0.02%	1076
2018 Q2	$7.95M	Buy	+80,037	New	+$6.92M	0.03%	706

Man Group's CBPO Position: Q2 2021 in Review

Man Group sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 30,897 shares — an estimated $3.66M sold.

Man Group first reported a position in CBPO in Q2 2018 and held it in 8 quarters. The position peaked at $18.1M in Q4 2019. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

Man Group reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
Man Group sold 30,897 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $3.66M.
Man Group first reported a position in China Biologic Products Holdings, Inc. in Q2 2018 and held it in 8 quarters.
Man Group's China Biologic Products Holdings, Inc. position peaked at $18.1M in Q4 2019.
0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on Man Group's 13F filing for Q2 2021, filed 16 Aug 2021.